Day: February 18, 2026

Preliminary blinded CR rate showed 67% improvement over historical cytarabine response Roughly 35% of the subjects treated to date represent ventoclax regimen failures First 45 subjects treated on track for Q1 2026 milestone with unblinding thereafter; treated 35 subjects to date with another 11 identified Continued absence of cardiotoxicity and high efficacy expected to position Annamycin as a “significant advancement” in AML treatment HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it is approaching the first unblinding of data in its pivotal Phase 2B/3 “MIRACLE” study of Annamycin in combination with cytarabine for the treatment of adult patients with acute myeloid leukemia (AML) who are refractory to or relapsed (R/R) after induction therapy...

Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals”) (TSXV: LMS, OTCQB: LMSQF) and Latin Explore Inc. (“Latin Explore”), updates that the previously announced spin-out transaction (the “Spin-Out“) of Latin Metals’ Para Copper Project (the “Para Project“) and Auquis Copper Project (the “Auquis Project“) into Latin Explore Inc. (“Latin Explore“) by way of a court-approved plan of arrangement under the provisions of the Business Corporations Act (British Columbia) (the “Arrangement“), has closed effective February 18,...

Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare Market Simple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in MinutesIRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced that Vietnam’s Hanoi Department of Health has officially approved the EZ Detect™ colorectal disease at-home screening test for sales and distribution throughout Vietnam. Biomerica is working with a major healthcare products distributor in Vietnam who will manage the sales and distribution of the product through pharmacies, hospitals, physician’s offices, and direct online sales channels. EZ Detect™ is an FDA-cleared two-minute at-home screening test designed to detect an early warning...

In-Depth Modeling, Simulation of Hypersonic Environments Will Lead to a Robust Set of Hypersonic Test Setpoints to Enable Rapid Evaluation, Transition of Various Thermal Protection System Materials SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, announced today that it has been awarded a contract through the Department of War’s Joint Hypersonics Transition Office to support test and evaluation of thermal protection systems for hypersonic vehicles. For this program, Kratos will leverage decades of expertise in hypersonics to analyze various missions and flight environments to understand appropriate testing conditions. Kratos will establish standard test conditions and techniques to accelerate materials...

BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers whose patients have coverage under Evernorth and Cigna Healthcare® plans. The Evernorth press release stated that the change will be effective on March 6, 2026. “Evernorth’s decision to eliminate the requirement for contracted providers to have patients obtain prior authorizations for TMS treatment marks an important step forward in...